Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 135,886 $ 165,586
Restricted cash 2,518 2,518
Accounts receivable, net of allowance of $8 and $39, respectively 5,491 2,629
Prepaid expenses and other current assets 5,044 6,264
Contract assets 2,865 1,678
Total current assets 151,804 178,675
Property and equipment - net 67,102 70,551
Goodwill 9,393 9,393
Investment in equity method investees 4,259 4,002
Intangible assets - net 2,339 2,480
Satellite procurement work in process 51,846 40,102
Other assets 565 560
Total assets 287,308 305,763
Current liabilities:    
Accounts payable and accrued liabilities 15,530 10,837
Amounts payable to equity method investees 3,951 5,613
Contract liabilities - current 9,528 11,266
Other current liabilities 2,619 2,819
Total current liabilities 31,628 30,535
Liability for estimated contract losses 3,626 6,054
Long-term contract liabilities 3,000 568
Derivative liabilities 8,786 16,925
Long-term debt - net of current portion 71,909 71,408
Other liabilities 1,463 653
Total liabilities 120,412 126,143
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Class A common stock, $0.0001 par value-authorized, 300,000 shares; issued, 120,506 and 117,160 shares; outstanding, 117,927 shares and 114,452 shares as of March 31, 2022 and December 31, 2021, respectively. 12 11
Additional paid-in capital 657,781 650,518
Accumulated deficit (490,897) (470,909)
Total stockholders’ equity 166,896 179,620
Total liabilities and stockholders’ equity $ 287,308 $ 305,763